Echotherapy

 

Our product: Echopulse®

+ Pathologies

+ Breast fibroadenoma

+ Thyroid nodules

 

 

 

 

HIFU technology News

HIFU technology Useful

HIFU technology FAQ

 

 

 

Our product: Echopulse®

Theraclion has used cutting-edge engineering techniques to develop the Echopulse® device. Echopulse® is based on unique echotherapy technology which combines focused ultrasound therapy (HIFU) with ultrasound monitoring. 

 

This dual functionality provides an accurate, tailored and non-invasive outpatient treatment for breast fibroadenomas and benign thyroid nodules.

 

The main components of the Echopulse® device are:

● Viewing and treatment unit (VTU)
● Integrated ultrasound scanner
● Scanning arms and motors
● Skin contact and cooling system
● Patient movement detector
● Touch-screen user interface

 

A four-stage procedure

 

Preparation

● Preparing the device
● Preparing and anaesthetising the patient

 

Viewing

● Positioning the treatment probe in the area to be treated and viewing the target area
● Precise electronic adjustment to lock onto the electronic target

 

Planning

● Outlining the target area on the ultrasound image in real time
● Planning the treatment sites

 

Treatment

● Sequential treatment (Pause & Pulse)
● Real-time ultrasound monitoring

 

 

 

Echopulse® is a medical device designed and marketed by Theraclion for use by health professionals in treating patients with breast fibroadenomas and benign thyroid nodules. It is a regulated health product and, in accordance with the above Act, it bears the CE marking. Consult your health professional before any procedure.

 

 

 

Print Friendly